Key Record Dates
| ClinicalTrials.gov Identifier: | NCT00940524 |
|---|---|
| Brief Title: | Induction Therapy With Cytarabine, High-Dose Mitoxantrone and Dasatinib for Patients With Philadelphia-Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia |
| First Submitted : | July 14, 2009 |
| First Submitted that Met QC Criteria : | July 15, 2009 |
| First Posted : | July 16, 2009 (Estimate) |
| Last Update Submitted that Met QC Criteria : | April 9, 2014 |
| Last Update Posted : | April 10, 2014 (Estimate) |